How Will the Food and Drug Administration Regulate Generative AI–Enabled Medical Devices?
Journal of Medical Internet Research · 2026-11-02 · 28 · e115030-e115030
DOI: 10.2196/115030 ↗At a glance
Journal article in Journal of Medical Internet Research, published online on 2026-11-02. Written by Simon Spichak. Major MEDLINE topics: United States Food and Drug Administration, Artificial Intelligence, Device Approval, Equipment and Supplies. The full text is freely available in PubMed Central.
Abstract (original language)
As the US Food and Drug Administration works to develop specific guidelines for the regulation of AI-enabled medical devices, could a previously cleared tool provide some clues as to what the new guidance will look like? In this News and Perspectives article, JMIR Correspondent Simon Spichak reports on and speaks with experts about the UpDoc diabetes management app and the future of AI regulation as AI-enabled devices continue to evolve.
Subjects
MeSH terms (MEDLINE)
Author keywords
Cite
APA
Spichak, S. (2026). How Will the Food and Drug Administration Regulate Generative AI–Enabled Medical Devices?. Journal of Medical Internet Research, 28, e115030-e115030. https://doi.org/10.2196/115030
Vancouver
Spichak S. How Will the Food and Drug Administration Regulate Generative AI–Enabled Medical Devices?. Journal of Medical Internet Research. 2026;28:e115030-e115030. doi:10.2196/115030
BibTeX
@article{Spichak2026,
author = {Spichak, Simon},
title = {How Will the Food and Drug Administration Regulate Generative AI–Enabled Medical Devices?},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e115030--e115030},
doi = {10.2196/115030}
}
EUVIMED